FDA preemption language in agency reform bill sought by NDMA.
This article was originally published in The Tan Sheet
Executive Summary
NDMA SEEKS "EXPRESS" LANGUAGE RECOGNIZING FDA REGULATORY PREEMPTION over states in FDA reform legislation with the aim of establishing uniform national requirements. In a March 8 statement to the Senate on Labor and Human Resources Committee, the Nonprescription Drug Manufacturers Association asked that such language be added to Committee Chairman Nancy Kassebaum's (R-Kan.) FDA reform bill (S 1477).